Ocumetra

Dublin, Ireland Founded: 2020 • Age: 6 yrs
Provider of myopia treatment analytics software

About Ocumetra

Ocumetra is a Healthcare company based in Dublin (Ireland) founded in 2020 by Ian Flitcroft and James Loughman. Provider of myopia treatment analytics software. Its website ocumetra.com draws about 10 thousand monthly visits. Ocumetra offers products and services including Clinical Tools, Communication Tools, and Partnership Program. Its focus areas include HealthTech, Healthcare IT, Provider and Clinical Operations. Its legal entity is OCUMETRA LIMITED.

Company details

Ocumetra was founded in 2020 in Dublin, Ireland, as a provider of analytics software focused on myopia treatment in the health technology sector. The platform offers growth chart tools for child health screening, along with centile analysis of ocular growth and refraction. Data analysis, disease diagnosis, and real-time data management features are included to support clinical operations in ophthalmology practices.

  • Headquarters Dublin, Ireland
  • Founders Ian Flitcroft, James Loughman
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website ocumetra.com
  • Social LinkedIn X Facebook
  • Legal Name Ocumetra Limited
Key Metrics

Products & Services of Ocumetra

Ocumetra offers a comprehensive portfolio of products and services, including Clinical Tools, Communication Tools, and Partnership Program.

Clinical Tools
Myopia Management

Tools for tracking and managing myopia progression in children.

Communication Tools
Patient Engagement

Tools to enhance clinician-patient interactions for eye health.

Partnership Program
Collaboration Platform

Program for building partnerships to expand myopia management services.

Funding Insights of Ocumetra

  • Total Rounds 1
  • Investors Count 1

All 1 funding rounds of Ocumetra with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Dec 2021Seed–Ocuco
–
Valuation history

1 investors in total: 1 institutional.

Investors in Ocumetra

Ocumetra has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Ocuco.

All
Institutional
InvestorDescriptionFounded YearDomainLocation
Practice management software for optometrists is provided by Ocuco.
1993ocuco.comDublin, Ireland
Premium access

Investor details for Ocumetra

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Ocumetra

13 people are tracked at Ocumetra (4 in leadership, 9 in board & advisors).

NameRoleGroup
Ian Flitcroft
Co-FounderLeadership
James Loughman
Co-FounderLeadership
Corrina McElduff
Director of Professional AffairsLeadership
Kate Loskutova
Director of OperationsLeadership
Brett Marshall
ISMS ConsultantBoard & advisors
Leo MacCanna
Board of Directors memberBoard & advisors
Zoya Ralph
Fractional CFOBoard & advisors
Tony O’Hanlon
Regulatory Affairs ConsultantBoard & advisors
Arthur Cummings
Chair of the BoardBoard & advisors
Richard Watson
Board of Directors memberBoard & advisors
Mayumi Kanai
Board of Directors memberBoard & advisors
Matteo Gubellini
Regulatory Affairs ConsultantBoard & advisors
Gareth Lingham
Clinical Data AnalystBoard & advisors
Premium access

Complete people profiles for Ocumetra

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Ocumetra

2 dated milestones of Ocumetra across 1 years, from founding to its latest funding, stage changes and deals.

  1. Founded Ocumetra is founded.
  2. Funding First funding round.

Web traffic of Ocumetra

The website of Ocumetra (ocumetra.com) receives about 10.2K visits a month.

  • Monthly visits
    10.2K

    ▲ 122.6% vs previous month

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Ocumetra

Premium access

Complete news archive for Ocumetra

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ocumetra

Ocumetra was founded in 2020 and raised its 1st funding round 1 year after it was founded.

Ocumetra is headquartered in Dublin, Ireland.

Ocumetra was founded in 2020 in Dublin, Ireland, as a provider of analytics software focused on myopia treatment in the health technology sector. The platform offers growth chart tools for child health screening, along with centile analysis of ocular growth and refraction. Data analysis, disease diagnosis, and real-time data management features are included to support clinical operations in ophthalmology practices.

Ocumetra offers Clinical Tools, Communication Tools, and Partnership Program.

Ocumetra has 1 investor. Key investors include Ocuco.

Ocumetra operates through Ocumetra Limited.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available